LLY

970.17

-3.27%↓

JNJ

236.59

-3.81%↓

ABBV

229.41

-2.38%↓

NVS

159.59

-2.94%↓

AZN

195.92

-3.16%↓

LLY

970.17

-3.27%↓

JNJ

236.59

-3.81%↓

ABBV

229.41

-2.38%↓

NVS

159.59

-2.94%↓

AZN

195.92

-3.16%↓

LLY

970.17

-3.27%↓

JNJ

236.59

-3.81%↓

ABBV

229.41

-2.38%↓

NVS

159.59

-2.94%↓

AZN

195.92

-3.16%↓

LLY

970.17

-3.27%↓

JNJ

236.59

-3.81%↓

ABBV

229.41

-2.38%↓

NVS

159.59

-2.94%↓

AZN

195.92

-3.16%↓

LLY

970.17

-3.27%↓

JNJ

236.59

-3.81%↓

ABBV

229.41

-2.38%↓

NVS

159.59

-2.94%↓

AZN

195.92

-3.16%↓

Inicio・Lista de Acciones・Avita Therapeutics Inc

Avita Therapeutics Inc

Abierto

4.81 -3.8

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

4.79

Máximo

5.01

Métricas clave
By Trading Economics
Ingresos	1.6M -12M
Ventas	554K 18M
BPA	-0.536
Margen de beneficios	-65.968
Empleados	226
EBITDA	1.6M -9.7M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+27.62% upside

Dividendos
By Dow Jones
Próximas Ganancias	7 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	38M 161M
Apertura anterior	8.61
Cierre anterior	4.81

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

8.83 / 9.77 Soporte y Resistencia

Avita Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

4 mar 2026, 23:39 UTC

Acciones populares

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4 mar 2026, 23:20 UTC

Ganancias

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4 mar 2026, 21:43 UTC

Ganancias

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4 mar 2026, 23:48 UTC

Charlas de Mercado

Nikkei May Rise After Recent Selloffs -- Market Talk

4 mar 2026, 23:33 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4 mar 2026, 23:24 UTC

Charlas de Mercado

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4 mar 2026, 22:30 UTC

Ganancias

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4 mar 2026, 22:30 UTC

Ganancias

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4 mar 2026, 22:30 UTC

Ganancias

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4 mar 2026, 22:13 UTC

Ganancias

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4 mar 2026, 22:13 UTC

Ganancias

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4 mar 2026, 22:13 UTC

Ganancias

Vermilion Energy 4Q EPS C$2.86 >VET

4 mar 2026, 22:04 UTC

Charlas de Mercado

RBA Slipping Behind The Curve On Rates -- Market Talk

4 mar 2026, 21:53 UTC

Ganancias

Lithium Americas 4Q Rev $66.8M >LAC

4 mar 2026, 21:53 UTC

Ganancias

Lithium Americas 4Q Loss/Shr 52c >LAC

4 mar 2026, 21:52 UTC

Ganancias

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar 2026, 21:50 UTC

Ganancias

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4 mar 2026, 21:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

4 mar 2026, 21:48 UTC

Ganancias

Webull 4Q Rev $165.2M >BULL

4 mar 2026, 21:48 UTC

Ganancias

Webull 4Q EPS 1c >BULL

4 mar 2026, 21:45 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 mar 2026, 21:45 UTC

Charlas de Mercado

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4 mar 2026, 21:40 UTC

Ganancias

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar 2026, 21:36 UTC

Noticias de Eventos Importantes

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4 mar 2026, 21:27 UTC

Ganancias

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar 2026, 21:17 UTC

Charlas de Mercado

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4 mar 2026, 21:16 UTC

Ganancias

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4 mar 2026, 21:15 UTC

Ganancias

Broadcom 1Q EPS $1.50 >AVGO

4 mar 2026, 21:15 UTC

Ganancias

Broadcom 1Q Net $7.35B >AVGO

4 mar 2026, 21:15 UTC

Ganancias

Broadcom 1Q Rev $19.31B >AVGO

Comparación entre iguales

Cambio de precio

Avita Therapeutics Inc previsión

Precio Objetivo

By TipRanks

27.62% repunte

Estimación a 12 Meses

Media 6.33 USD 27.62%

Máximo 10 USD

Mínimo 3.5 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Avita Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para Avita Therapeutics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

8.83 / 9.77Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.